Professor at the KU Leuven in Belgium and at the University of Amsterdam in the Netherlands.
Professor Frédéric Amant, MD, PhD is Professor in the Department of Oncologyat the University of Leuven, Belgium and a specialist in Gynecologic Oncology in UZ Gasthuisberg, Leuven. As the principle investigator of an international study on cancer in pregnancy and a key member of multiple European specialist groups, including EORTC and ENITEC, Professor Amant has been described by The Lancet as ‘leading the agenda on cancer in pregnancy’. He also chairs the International Network on Cancer, Infertility and Pregnancy (INCIP). Recent publications include a series on malignancy in pregnancy published in the Lancet Oncology and Journal of Clinical Oncology, which presented new evidence on the treatment of cancer during pregnancy. During the ISUOG keynote lecture Professor Amant will give an overview of cancer treatment modalities during pregnancy. Radiotherapy and chemotherapy are possible under certain conditions without jeopardizing fetal chances. He will show that children suffer more from prematurity than from antenatal exposure to chemotherapy. In addition, the need for a multidisciplinary approach and high risk obstetrical unit will be emphasised.